The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 08, 2024

Filed:

Jul. 03, 2019
Applicant:

University of Florida Research Foundation, Incorporated, Gainesville, FL (US);

Inventors:

Dorina Avram, Tampa, FL (US);

Benjamin George Keselowsky, Gainesville, FL (US);

Joshua Stewart, Gainesville, FL (US);

Jonathan Joseph Cho, Gainesville, FL (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/59 (2017.01); A61K 31/203 (2006.01); A61K 31/436 (2006.01); A61K 31/593 (2006.01); A61K 38/18 (2006.01); A61K 38/19 (2006.01); A61K 38/20 (2006.01); A61K 39/00 (2006.01); A61P 25/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/593 (2017.08); A61K 31/203 (2013.01); A61K 31/436 (2013.01); A61K 31/593 (2013.01); A61K 38/1841 (2013.01); A61K 38/1866 (2013.01); A61K 38/193 (2013.01); A61K 38/2066 (2013.01); A61K 39/0008 (2013.01); A61P 25/00 (2018.01);
Abstract

Provided are a dual microparticle system to treat Multiple Sclerosis, the system comprising phagocytosable and non-phagocytosable microparticles for delivery of at least one antigen, at least one immunomodulatory agent, at least one immunosuppressive agent and at least one chemoattractant to a subject suffering from Multiple Sclerosis to generate tolerogenic dendritic cells in the subject and treat the Multiple Sclerosis.


Find Patent Forward Citations

Loading…